NCT04745377View on ClinicalTrials.gov

Responses to COVID-19 Vaccination in Patients With Cancer

CompletedOBSERVATIONAL
Enrollment

332

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

October 14, 2021

Study Completion Date

May 20, 2022

Conditions
Cancer
Interventions
DIAGNOSTIC_TEST

IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus

IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus

Trial Locations (1)

18547

Metropolitan Hospital, Athens

All Listed Sponsors
lead

Hellenic Cooperative Oncology Group

OTHER

NCT04745377 - Responses to COVID-19 Vaccination in Patients With Cancer | Biotech Hunter | Biotech Hunter